ARS Pharmaceuticals, Inc. — SCHEDULE 13G Filings
3 SCHEDULE 13G filings on record
This page lists all SCHEDULE 13G filings submitted to the SEC by ARS Pharmaceuticals, Inc. (SPRY), sorted by most recent first. Each row links to the full filing on EdgarLookup. ARS Pharmaceuticals, Inc. has filed 3 SCHEDULE 13G documents with the SEC since 2016. To view all SEC filings by ARS Pharmaceuticals, Inc., see the full filings list.
All
10-K
10-Q
10-Q/A
144
144/A
3
3/A
4
4/A
424B4
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DEFM14A
DRS
EFFECT
PREM14A
PRER14A
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G | — | 0001104659-26-033875 | Mar 24, 2026 | — |
| SCHEDULE 13G | — | 0001104659-26-015245 | Feb 13, 2026 | — |
| SCHEDULE 13G | — | 0002012383-26-000722 | Jan 21, 2026 | — |